| Document |
Document Title |
|
WO/2023/041203A1 |
The invention is in the field of bacterial strains isolated from the mammalian digestive tract and the use of such strains, and compositions comprising these strains, in the treatment of disease.
|
|
WO/2023/039936A1 |
Provided are an expression cassette for expressing a gene containing an overlapping open reading frame in an insect cell, and the use thereof. The expression cassette contains, from 5' to 3', a promoter capable of driving transcription i...
|
|
WO/2023/043111A1 |
The present invention pertains to: a novel microorganism; a lysate, a culture, and an extract thereof; and a use thereof for improving hair or scalp condition. A novel Paracoccus denitrificans strain according to an aspect has the effect...
|
|
WO/2023/039645A1 |
The present invention relates to new strains of Enterococcus sp., in particular, inflammatory and non-inflammatory strains of Enterococcus sp., useful for bacterio therapy.
|
|
WO/2023/039921A1 |
Provided are a composite microbial agent for degrading petroleum hydrocarbons, and a preparation method therefor and the use thereof. The composite microbial agent is composed of live Acinetobacter KJ-1 with the deposit number of CGMCC N...
|
|
WO/2023/040426A1 |
Provided are a formula of probiotics and metabolites thereof for alleviating metabolic syndromes, and the use thereof. The formula comprises Lactobacillus reuteri PLBK®1, Lactobacillus reuteri PLBK®2, Lactobacillus gasseri PLBK ®3, La...
|
|
WO/2023/035527A1 |
Provided is engineered Escherichia coli for producing olivetol and olivetolic acid. An Escherichia coli fabH gene is deleted and an olivetol synthase is expressed, thereby improving the yield of olivetol and olivetolic acid.
|
|
WO/2023/035396A1 |
Provided are an olivetol synthetase variant and an engineered Escherichia coli expressing same for the production of olivetol and olivetolic acid. The engineered Escherichia coli is modified to express an olivetol synthetase variant whic...
|
|
WO/2023/038418A1 |
The present invention relates to a bifidobacterium bifidum EPS DA-LAIM strain (KCTC 14638BP) for intestinal health, having the effect of promoting growth of lactobacillus, polysaccharides produced from same, and a composition comprising ...
|
|
WO/2023/038258A1 |
The present invention relates to a Lactobacillus gasseri LM1065 strain (KCCM13018P), and a composition, for alleviating premenstrual syndrome, comprising same. The Lactobacillus gasseri LM1065 strain (KCCM13018P) according to one impleme...
|
|
WO/2023/035357A1 |
Provided are a lipase mutant and an application thereof. Specifically, one or more mutations selected from A262H, A338V, V364I, A158P/V, and I159N are generated on the basis of an amino acid sequence as shown in SEQ ID NO: 1; compared wi...
|
|
WO/2023/038485A1 |
The present invention relates to a bio-converting enzyme for obtaining ginsenoside from ginseng. When used to ferment ginseng, the bio-converting enzyme of the present invention can produce more Rh2, which is excellent in treating cancer...
|
|
WO/2023/035858A1 |
A conidia coating method for producing sexual generations of Magnaporthe oryzae in quantity. The method comprises: 1) preparing a conidia suspension of different mating types of Magnaporthe oryzae; 2) coating an oat culture medium with t...
|
|
WO/2023/038282A1 |
The present invention relates to a novel microorganism Bacillus subtilis ps4060 KACC81161BP having an excellent ability of producing surfactin, a protease, and a polysaccharide lyase, the novel microorganism Bacillus subtilis ps4060 KACC...
|
|
WO/2023/035437A1 |
Provided are a microalgae culture medium and a method for degrading algae toxins. The microalgae culture medium is composed of potassium peroxymonosulfate, sodium dehydroacetate, sodium citrate, alpha hydroxy acid, glacial acetic acid, s...
|
|
WO/2023/035027A1 |
The invention relates to a method of biocementation comprising applying at a location of a granular substrate a first component comprising an alkalophilic ureolytic calcifying bacterium and a soluble Ca2+ salt in a medium of pH 10 to abo...
|
|
WO/2023/036823A1 |
Provided are methods for increasing the growth of Moorella species bacteria, genetically modified bacteria derived from such methods, and use of such bacteria for metabolizing a carbon-containing substrate, optionally in the production o...
|
|
WO/2023/035584A1 |
Disclosed in the present invention are yeast engineering bacteria for fermentative production of heparin, and construction and an application thereof. In the present invention, the exogenous gene heparin precursor synthase gene (glucuron...
|
|
WO/2023/038419A1 |
The present invention relates to intestinal health strain Lactobacillus paracasei EPS DA-BACS having Lactobacillus bifidus growth promotion and harmful intestinal bacteria Clostridium difficile inhibitory effects, and polysaccharide ther...
|
|
WO/2023/038404A1 |
The present invention relates to a novel Bifidobacterium animalis subsp. lactis DS008 strain, a composite fermented extract of licorice, thistle and Lonicerae Folium using said strain, and the use thereof for improving skin condition. Th...
|
|
WO/2023/035857A1 |
A conidia coating method for producing a large number of sexual generations of Pyricularia oryzae, comprising 1) preparing conidia suspensions of different mating types of Pyricularia oryzae; 2) on an oat medium, coating, in proportion, ...
|
|
WO/2023/029568A1 |
Disclosed are a lactic acid bacteria culture medium having a specificity, a culture method therefor and a use thereof. The culture medium comprises: adding to every 1 L of tap water 8 to 12 g of tryptone, 10 to 15 g of beef extract, 8 to...
|
|
WO/2023/030967A1 |
The present invention relates to biotechnological methods for producing saturated and unsaturated aldehydes, and mixtures thereof having at least one alpha-dioxygenase and at least one aldehyde dehydrogenase. The method can be carried ou...
|
|
WO/2023/033626A1 |
The present invention relates to a composition for prevention or treatment of cancer, the composition containing, as an active ingredient, a Leuconostoc pseudomesenteroides WiKim0138 strain isolated from kimchi or a culture thereof. The ...
|
|
WO/2023/033408A1 |
The present invention relates to: a composition for controlling diseases and pests in plants, comprising a culture broth of a Streptomyces sp. JCK-6131 strain or an extract thereof; a method for preparing same; and a method for controlli...
|
|
WO/2023/033624A1 |
The present invention relates to a composition for preventing or treating cancer, the composition comprising, as an active ingredient, Weissella paramesenteroides WiKim0137 or a culture thereof isolated from kimchi. The Weissella parames...
|
|
WO/2023/029569A1 |
Disclosed in the present invention are a strain HSCY 2073, and a separation and screening method therefor and the use thereof in improving the flavor and quality of vinegar. The strain is identified as a Lactobacillus, and is already dep...
|
|
WO/2023/030496A1 |
A method for the stable and efficient production of pneumocandin B0 by feeding a fermentation process. By means of adding one or more of lactic acid, mannitol or γ-aminobutyric acid during a fermentation process, the fermentation level ...
|
|
WO/2023/027529A1 |
The present invention relates to a Bacillus thuringiensis JNU01 (accession number: KCTC 14427BP) strain having a plastic decomposition activity. The Bacillus thuringiensis JNU01 strain according to the present invention can decompose pla...
|
|
WO/2023/025235A1 |
Provided is use of exopolysaccharides of a lactic acid bacterium or a pharmaceutical composition comprising the exopolysaccharides in the manufacture of a medicament for preventing, ameliorating and/or treating a sleeping disorder in a s...
|
|
WO/2023/025292A1 |
Provided is Bacillus coagulans DHE002 preserved and numbered as CGMCC NO.23118. Meanwhile, provided is a method for catalytic production of 2'-deoxyadenosine by fermenting and culturing Bacillus coagulans DHE002 as an enzyme source.
|
|
WO/2023/024828A1 |
Disclosed in the present invention are a glycosyltransferase mutant and a method for catalytic synthesis of rebaudioside M by means of using same. The mutant is obtained by means of performing a mutation on the basis of an amino acid seq...
|
|
WO/2023/019723A1 |
Provided are a monoclonal antibody 32C7, and a preparation method therefor and the use thereof. The monoclonal antibody can effectively and specifically bind to a RBD domain of a S protein of a novel coronavirus, and in-vivo replication ...
|
|
WO/2023/022628A1 |
The invention relates to the field of biotechnology. Claimed is a planktonic eurybiontic strain of unicellular green microalgae Chlorella sorokiniana AGT, capable of photosynthesis at temperatures of from 6°С, deposited in the Russian ...
|
|
WO/2023/019821A1 |
The present invention provides an azaphilone polymer compound, and a preparation method therefor and the use thereof. According to the present invention, muyocopronlaterale is fermented and cultured, and a fermentation product is separat...
|
|
WO/2023/020634A1 |
Disclosed is a genetically engineered bacteria having enhanced superoxide dismutase activity. Using the genetically engineered bacteria can improve the conversion rate of substrates and the yield of products, and shorten the fermentation...
|
|
WO/2023/019724A1 |
Provided are a monoclonal antibody 35B5, a preparation method therefor, and a use thereof. By preparing a neutralizing antibody 35B5 against the RBD domain of a novel coronavirus, it is verified in vitro, by means of surface plasmon reso...
|
|
WO/2023/020191A1 |
Disclosed in the present application are an Exiguobacterium indicum YAN2 having high-concentration selenite tolerance, the preservation number thereof being GDMCC No. 61594, and a method for fermenting inorganic selenium into nano-seleni...
|
|
WO/2023/019671A1 |
A method and a kit for constructing a fluorescent oligonucleotide standard curve. The method comprises: step 1, using an aqueous solution of ammonia to formulate a standard solution of fluorescent oligonucleotide. The fluorescent oligonu...
|
|
WO/2023/019987A1 |
The present invention belongs to the field of food processing, and discloses a neutral exopolysaccharide of lactobacillus plantarum and the use thereof. The neutral exopolysaccharide of lactobacillus plantarum of the present invention is...
|
|
WO/2023/023195A1 |
Provided herein are dairy-like analogue compositions and the methods of making the same using recombinant single variants of casein proteins, including, for example, recombinant single variants of alpha casein proteins.
|
|
WO/2023/019693A1 |
The present invention designs and constructs five artificial non-coding RNAs, respectively. The sequence of each artificial non-coding RNA has a complementary pairing region with a target mRNA, a binding site of an Hfq protein, and a Rho...
|
|
WO/2023/023642A2 |
The present disclosure is generally related to recombinant microbial cells expressing heterologous proteins of interest. Certain aspects of the disclosure are therefore related to, inter alia, recombinant Bacillus cells having enhanced p...
|
|
WO/2023/018718A1 |
This disclosure describes recombinant Megasphaera microbes designed to include increased consumption of acetate, increased carbon flux to butyryl-CoA and/or hexanoyl-CoA, increased production of butyrate and/or hexanoate, or a combinatio...
|
|
WO/2023/015965A1 |
Provided are a high immune yeast cell wall, and a preparation method therefor and the use thereof. For the high immune yeast cell wall, the dissolution rate is ≥ 40%, glucan with a relative molecular weight of 80-200 kDa accounts for m...
|
|
WO/2023/015870A1 |
Provided in the present invention are a method for constructing a strain for producing a recombinant protein containing unnatural amino acids, and the strain obtained therefrom. The method comprises modifying the expression of a prfA gen...
|
|
WO/2023/018691A1 |
Disclosed herein are compositions and methods for preventing, ameliorating, or treating pathogenic infections in aquaculture and/or reducing the severity of one or more risk factors, signs, or symptoms associated with pathogenic infectio...
|
|
WO/2023/018077A1 |
The present invention relates to: a Microccocus cohnii MC-2 strain; a lysate, a culture solution, and an extract solution thereof; a composition comprising same; and a use thereof for improving the condition of skin. A novel Microccocus ...
|
|
WO/2023/015805A1 |
A Bacillus velezensis bred by ultrasound-assisted adaptive evolution, and an application thereof. The Bacillus velezensis comprises a Bacillus velezensis stain US-ALE-BV3 with a preservation number of CGMCC No. 22846 and a Bacillus velez...
|
|
WO/2023/015441A1 |
Provided are a light-controlled lysis engineering bacterium, and a construction method therefor and the use thereof. The light-controlled lysis engineering bacterium can respectively express a photosensitive protein, an anti-termination ...
|
